Molecular mechanisms of diabetic retinopathy: potential therapeutic targets
- PMID: 25949069
- PMCID: PMC4411608
- DOI: 10.4103/0974-9233.154386
Molecular mechanisms of diabetic retinopathy: potential therapeutic targets
Abstract
Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults in United States. Research indicates an association between oxidative stress and the development of diabetes complications. However, clinical trials with general antioxidants have failed to prove effective in diabetic patients. Mounting evidence from experimental studies that continue to elucidate the damaging effects of oxidative stress and inflammation in both vascular and neural retina suggest its critical role in the pathogenesis of DR. This review will outline the current management of DR as well as present potential experimental therapeutic interventions, focusing on molecules that link oxidative stress to inflammation to provide potential therapeutic targets for treatment or prevention of DR. Understanding the biochemical changes and the molecular events under diabetic conditions could provide new effective therapeutic tools to combat the disease.
Keywords: Diabetic Retinopathy; Endoplasmic Reticulum-stress; Inflammation; Nicotinamide Adenine Dinucleotide Phosphate Oxidase; Oxidative Stress; Peroxynitrite; Therapeutics.
Conflict of interest statement
Figures

Similar articles
-
Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target.Eur J Pharmacol. 2019 Jun 15;853:381-387. doi: 10.1016/j.ejphar.2019.04.038. Epub 2019 Apr 19. Eur J Pharmacol. 2019. PMID: 31009636 Review.
-
Acrolein: A Potential Mediator of Oxidative Damage in Diabetic Retinopathy.Biomolecules. 2020 Nov 20;10(11):1579. doi: 10.3390/biom10111579. Biomolecules. 2020. PMID: 33233661 Free PMC article. Review.
-
Diabetic retinopathy: current management and experimental therapeutic targets.Pharmacotherapy. 2009 Feb;29(2):182-92. doi: 10.1592/phco.29.2.182. Pharmacotherapy. 2009. PMID: 19170588 Review.
-
Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress.Life Sci. 2018 Jan 15;193:20-33. doi: 10.1016/j.lfs.2017.12.001. Epub 2017 Dec 5. Life Sci. 2018. PMID: 29203148 Review.
-
Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.Pharmacol Res. 2019 Sep;147:104299. doi: 10.1016/j.phrs.2019.104299. Epub 2019 Jun 15. Pharmacol Res. 2019. PMID: 31207342 Free PMC article. Review.
Cited by
-
The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases.Cell Biosci. 2022 Jan 3;12(1):1. doi: 10.1186/s13578-021-00736-9. Cell Biosci. 2022. PMID: 34980273 Free PMC article. Review.
-
Deletion of the Neurotrophin Receptor p75NTR Prevents Diabetes-Induced Retinal Acellular Capillaries in Streptozotocin-Induced Mouse Diabetic Model.J Diabetes Metab Disord Control. 2017;4(6):129. doi: 10.15406/jdmdc.2017.04.00129. Epub 2017 Dec 21. J Diabetes Metab Disord Control. 2017. PMID: 29658956 Free PMC article.
-
The Therapeutic Role of Carotenoids in Diabetic Retinopathy: A Systematic Review.Diabetes Metab Syndr Obes. 2020 Jul 3;13:2347-2358. doi: 10.2147/DMSO.S255783. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 32753919 Free PMC article. Review.
-
Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications.Diabetes Metab Syndr Obes. 2020 Jan 7;13:43-51. doi: 10.2147/DMSO.S232221. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 32021350 Free PMC article. Review.
-
Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond.Cardiovasc Endocrinol Metab. 2020 May 18;10(1):3-13. doi: 10.1097/XCE.0000000000000209. eCollection 2021 Mar. Cardiovasc Endocrinol Metab. 2020. PMID: 33634250 Free PMC article. Review.
References
-
- American Diabetes Association, editor. American Diabetes Association: All About Diabetes. ADA. 2014. [Last accessed on 2014 Oct 10].
-
- Ey C. Pathophysiology of diabetic retinopathy. In: LeRoith D, Breen TL, Olefsky JM, editors. Diabetes Mellitus: A Fundamental and Clinical Text. Philadelphia, PA: Lippincott Williams and Wilkins; 2004.
-
- Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48–58. - PubMed
-
- Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–88. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical